Related Experiment Videos
How do you know who needs prevention or treatment?
1Department of Rheumatology, Saint-Luc University Hospital, Louvain University, Brussels, Belgium.
Bailliere'S Clinical Rheumatology
|August 1, 1997
Summary
Osteoporosis is preventable with available treatments. Bone mass measurement combined with clinical risk factors and individual assessment guides appropriate osteoporosis therapy, avoiding misassignation.
Area of Science:
- Geriatrics
- Orthopedics
- Endocrinology
Background:
- Osteoporosis management requires accurate patient identification for effective treatment.
- Relying solely on clinical risk factors can lead to inappropriate therapeutic decisions for osteoporosis.
- Bone mass measurement is crucial for accurate fracture risk assessment.
Purpose of the Study:
- To emphasize the importance of accurate risk assessment in osteoporosis treatment.
- To highlight the complementary roles of bone mass measurement and clinical factors in therapeutic decisions.
- To guide optimal therapeutic intervention for osteoporosis.
Main Methods:
- Evaluating the utility of clinical risk factors versus bone mass measurement for fracture risk.
- Assessing the impact of clinical factors in modulating bone mass-based therapeutic decisions.
- Considering multifactorial assessments, including non-bone mineral factors, in elderly patients.
Main Results:
- Clinical risk factors alone may be misleading for osteoporosis treatment decisions.
- Bone mass measurement provides a more accurate assessment of future fracture risk.
- In the very elderly, clinical factors and non-bone mineral assessments gain importance alongside bone density.
Conclusions:
- Optimal osteoporosis treatment balances bone mineral density thresholds with individualized clinical evaluation.
- Therapeutic decisions for osteoporosis should not be solely based on automated data.
- A comprehensive approach integrating bone density and clinical judgment ensures appropriate patient management.